Are you Dr. Liu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Yaw 7
Boston, MA 02114Phone+1 617-724-6862Fax+1 617-724-1135
Summary
- Dr. Geoffrey Liu, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1998 - 2001
- University of Toronto Faculty of MedicineClass of 1993
Certifications & Licensure
- MA State Medical License 1997 - 2026
Publications & Presentations
PubMed
- 25 citationsReal-World EQ5D Health Utility Scores for Patients With Metastatic Lung Cancer by Molecular Alteration and Response to Therapy.Catherine Labbé, Yvonne W. Leung, João Gabriel Silva Lemes, Erin L. Stewart, Catherine Brown
Clinical Lung Cancer. 2017-07-01 - 7 citationsRoutine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (P...Tian Qi Wang, Joseph Samuel, M. Catherine Brown, Ashlee Vennettilli, Hannah Solomon
Oncology and Therapy. 2018-10-22 - 34 citationsFc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal CancerGeoffrey Liu, Dongsheng Tu, Marcia Lewis, Dangxiao Cheng, Leslie A. Sullivan
Clinical Cancer Research. 2016-05-15
Press Mentions
- Adela Announces Clinical Validation Results for Head & Neck Cancer MRD Test Simultaneously Published in Annals of Oncology and Presented at ESMO 2024September 14th, 2024
- Gene Variation Affects Survival Benefits with Cetuximab in Colorectal CancerMay 15th, 2016
- Pentavere: Transforming the Healthcare Industry with Innovative Data-Driven AI EngineMay 5th, 2021